Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconINSMInsmed$43.51bnn/an/a
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconIQVIqvia Holdings$38.46bn29.46n/a
us flag iconBNTXBioNTech SE$23.14bnn/an/a
us flag iconEXASExact Sciences$19.18bnn/an/a
us flag iconMEDPMedpace Holdings$15.40bn38.34n/a
us flag iconRVMDRevolution Medicines$15.40bnn/an/a
us flag iconICLRIcon$14.19bn18.3n/a
us flag iconTEMTempus AI$13.64bnn/an/a
us flag iconSMMTSummit Therapeutics$13.63bnn/an/a
us flag iconIONSIonis Pharmaceuticals$13.23bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$13.11bnn/an/a
us flag iconASNDAscendis Pharma A/S$12.67bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconEXELExelixis$11.89bn18.25n/a
us flag iconQGENQiagen NV$10.19bn23.75n/a
us flag iconTECHBIO-TECHNE$9.61bn50.240.52%
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconCRLCharles River Laboratories International$9.07bn57.06n/a
us flag iconIMGNImmunoGen$8.72bnn/an/a